SIM
IONS icon

Sonora Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sonora Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5.49M Sell
163,703
-4,962
-3% -$187K 0.69% 56
2021
Q2 		$6.73M Buy
168,665
+4,742
+3% +$186K 0.88% 44
2021
Q1 		$7.37M Buy
163,923
+12,928
+9% +$721K 0.58% 62
2020
Q4 		$8.54M Buy
150,995
+20,796
+16% +$1.04M 0.71% 46
2020
Q3 		$6.18M Buy
130,199
+19,521
+18% +$1.08M 0.57% 58
2020
Q2 		$6.53M Sell
110,678
-1,584
-1% -$88.1K 0.67% 52
2020
Q1 		$5.31M Sell
112,262
-3,501
-3% -$195K 0.63% 49
2019
Q4 		$6.99M Sell
115,763
-1,246
-1% -$74.2K 0.66% 50
2019
Q3 		$7.01M Buy
117,009
+4,201
+4% +$274K 0.73% 41
2019
Q2 		$7.25M Sell
112,808
-785
-0.7% -$55.5K 0.81% 39
2019
Q1 		$9.22M Sell
113,593
-673
-0.6% -$43.4K 1.13% 20
2018
Q4 		$6.18M Sell
114,266
-3,168
-3% -$162K 0.9% 32
2018
Q3 		$6.06M Sell
117,434
-718
-0.6% -$33.7K 0.84% 36
2018
Q2 		$4.92M Sell
118,152
-500
-0.4% -$22.2K 0.76% 47
2018
Q1 		$5.23M Sell
118,652
-461
-0.4% -$23.4K 0.83% 42
2017
Q4 		$5.99M Buy
119,113
+1,034
+0.9% +$56.7K 0.96% 30
2017
Q3 		$5.99M Sell
118,079
-1,779
-1% -$93.2K 1.04% 28
2017
Q2 		$6.1M Buy
119,858
+141
+0.1% +$6.57K 1.15% 27
2017
Q1 		$4.81M Sell
119,717
-1,986
-2% -$89.2K 0.93% 33
2016
Q4 		$5.82M Sell
121,703
-3,110
-2% -$123K 1.2% 28
2016
Q3 		$4.57M Buy
124,813
+1,245
+1% +$39K 0.96% 33
2016
Q2 		$2.88M Buy
123,568
+645
+0.5% +$20.8K 0.66% 44
2016
Q1 		$5.3M Sell
122,923
-3,840
-3% -$156K 1.27% 27
2015
Q4 		$7.85M Sell
126,763
-341
-0.3% -$18.4K 2.04% 10
2015
Q3 		$6.62M Buy
+127,104
New +$6.58M 2% 15

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sonora Investment Management's IONS Position: Q3 2021 in Review

Sonora Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 2.9% in Q3 2021, selling an estimated $187K and leaving 163,703 shares worth $5.49M. The position accounts for 0.69% of the portfolio, ranked #56.

Sonora Investment Management first reported a position in IONS in Q3 2015 and has held it in 25 quarters since. The position peaked at $9.22M in Q1 2019. 325 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Sonora Investment Management held 163,703 shares of Ionis Pharmaceuticals worth $5.49M as of Q3 2021.
  • Sonora Investment Management sold 4,962 Ionis Pharmaceuticals shares in Q3 2021, an estimated $187K.
  • Ionis Pharmaceuticals made up 0.69% of Sonora Investment Management's portfolio in Q3 2021, its #56 holding.
  • Sonora Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
  • Sonora Investment Management's Ionis Pharmaceuticals position peaked at $9.22M in Q1 2019.
  • 325 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.